These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy. DeMeester SR Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209 [No Abstract] [Full Text] [Related]
3. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related]
4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Zehetner J; DeMeester SR Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671 [TBL] [Abstract][Full Text] [Related]
6. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Maish MS; DeMeester SR Ann Thorac Surg; 2004 Nov; 78(5):1777-82. PubMed ID: 15511474 [TBL] [Abstract][Full Text] [Related]
7. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Peyre CG; DeMeester SR; Rizzetto C; Bansal N; Tang AL; Ayazi S; Leers JM; Lipham JC; Hagen JA; DeMeester TR Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503 [TBL] [Abstract][Full Text] [Related]
8. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance]. Burdiles P; Csendes A; Smok G; Braghetto I; Korn O Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585 [TBL] [Abstract][Full Text] [Related]
9. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction]. von Rahden BH; Feith M; Stein HJ Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis. Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Barrett's esophagus with high-grade dysplasia. McAllaster JD; Buckles D; Al-Kasspooles M Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509 [TBL] [Abstract][Full Text] [Related]
12. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma. Gilbert S; Jobe BA Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741 [TBL] [Abstract][Full Text] [Related]
13. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Schembre DB; Huang JL; Lin OS; Cantone N; Low DE Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860 [TBL] [Abstract][Full Text] [Related]
15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
16. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106 [TBL] [Abstract][Full Text] [Related]
17. Laparoscopic transgastric esophageal mucosal resection: 4-year minimum follow-up. Frantzides CT; Carlson MA; Keshavarzian A; Roberts JE Am J Surg; 2010 Aug; 200(2):305-7. PubMed ID: 20188346 [TBL] [Abstract][Full Text] [Related]
19. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Moraca RJ; Low DE Arch Surg; 2006 Jun; 141(6):545-9; discussion 549-51. PubMed ID: 16785354 [TBL] [Abstract][Full Text] [Related]
20. SSAT controversies intramucosal esophageal cancer and high-grade dysplasia: which treatment? Surgical therapy: improved outcomes and piece of mind. Peters JH J Gastrointest Surg; 2009 Jul; 13(7):1179-81. PubMed ID: 19294473 [No Abstract] [Full Text] [Related] [Next] [New Search]